🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypothesis of this trial is that the test drug (Eritromax ®) pharmacoki...
Status
Completed
Location
LAL Clinica
Start Date
2013-02-28
Trial ID
NCT01685333
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested
The purpose of this study is to determine if EL219 is safe and effective co...
Status
Recruiting
Location
U. of Alabama at Birmingham
Start Date
2026-02-13
Trial ID
NCT07215273
Treatments Being Tested
The hypothesis of this trial is that the test drug (Eritromax ®) pharmacoki...
Status
Unknown
Location
LAL Clínica
Start Date
2013-02
Trial ID
NCT01664195
Treatments Being Tested
Breast cancer is the second most common form of cancer in women and the mos...
Status
Withdrawn
Location
Sunnybrook Health Sciences Centre
Start Date
2017-11-21
Trial ID
NCT03121989
Treatments Being Tested
This study aims to compare the pharmacokinetics of naloxone when administer...
Status
Unknown
Location
International Pharmaceutical Research Center (IPRC)
Start Date
2012-06
Trial ID
NCT01622504
Treatments Being Tested
This study will design an alternative urodynamic platform to better evaluat...
Status
Completed
Location
Multiple Locations
Start Date
2008-09-03
Trial ID
NCT00768521
Treatments Being Tested
An open-label, randomized, fasting, single-dose, oral administration, 2-seq...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-10
Trial ID
NCT07584304
The purpose of the Phase Ib portion is to find out the highest dose of stud...
Status
Terminated
Location
Multiple Locations
Start Date
2011-09-30
Trial ID
NCT01347645
This is a prospective, exploratory, double-blind, single-visit internal val...
Status
Completed
Location
NovoBliss Research
Start Date
2025-11-14
Trial ID
NCT07333300
Treatments Being Tested